Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer.

Emilia ZampellaLeandra PiscopoMariarosaria ManganelliFabio VolpeCarmela NappiValeria GaudieriLeonardo PaceMartin SchlumbergerAlberto CuocoloMichele Klain

Published in: Endocrine (2023)

In pediatric patients with DTC, the response to therapy evaluated 12 months after initial treatment has an independent prognostic impact and is able to predict mid-term outcome. Patients with no-ER at 12 months after RAI therapy should be closely followed-up.

Keyphrases

stem cells
squamous cell carcinoma
papillary thyroid
cell therapy
bone marrow
young adults
replacement therapy